ACNV — Accelera Innovations Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.05m
- $0.00m
2012 December 31st | C2013 December 31st | 2014 December 31st | R2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.376 | 2.72 | 1.13 | 0.003 |
Cost of Revenue | |||||
Gross Profit | — | 0.376 | 1.03 | 0.976 | 0.003 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.11 | 7.64 | 38.8 | 14.2 | 1.9 |
Operating Profit | -5.11 | -7.26 | -36.1 | -13 | -1.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.11 | -7.26 | -36.1 | -14.8 | -1.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.11 | -7.26 | -36.1 | -14.8 | -1.93 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.11 | -7.4 | -36.3 | -14.8 | -1.93 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -5.11 | -7.4 | -36.3 | -14.9 | -1.97 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.244 | -0.336 | -0.986 | -0.346 | -0.04 |
Dividends per Share |